989 related articles for article (PubMed ID: 29398533)
41. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
[TBL] [Abstract][Full Text] [Related]
42. Preprocedure Intravenous Recombinant Tissue Plasminogen Activator and Risk of Distal Embolization with Thrombectomy in Acute Ischemic Stroke.
Qureshi AI; Asif A; Aytac E; Liaqat J; Gurkas E; Lobanova I; Saeed O; Ahsan H; Siddiq F; Gomez CR; French BR
J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104362. PubMed ID: 31562039
[TBL] [Abstract][Full Text] [Related]
43. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
Kim DH; Lee DS; Nah HW; Cha JK
BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
[TBL] [Abstract][Full Text] [Related]
44. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
Takahashi W; Moriya Y; Mizuma A; Uesugi T; Ohnuki Y; Takizawa S
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e528-32. PubMed ID: 23830955
[TBL] [Abstract][Full Text] [Related]
45. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
[TBL] [Abstract][Full Text] [Related]
46. Accuracy of Stroke Diagnosis in Telestroke-Guided Tissue Plasminogen Activator Patients.
Agrawal K; Raman R; Ernstrom K; Claycomb RJ; Meyer DM; Hemmen TM; Modir RF; Kachhi P; Meyer BC
J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2942-2946. PubMed ID: 27599906
[TBL] [Abstract][Full Text] [Related]
47. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
[TBL] [Abstract][Full Text] [Related]
48. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
Adeoye O; Knight WA; Khoury J; Schmit PA; Sucharew H; Broderick JP; Pancioli AM;
J Stroke Cerebrovasc Dis; 2014; 23(5):e313-5. PubMed ID: 24534128
[TBL] [Abstract][Full Text] [Related]
49. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
[TBL] [Abstract][Full Text] [Related]
50. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
[TBL] [Abstract][Full Text] [Related]
51. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
[TBL] [Abstract][Full Text] [Related]
52. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
Pancioli AM; Adeoye O; Schmit PA; Khoury J; Levine SR; Tomsick TA; Sucharew H; Brooks CE; Crocco TJ; Gutmann L; Hemmen TM; Kasner SE; Kleindorfer D; Knight WA; Martini S; McKinney JS; Meurer WJ; Meyer BC; Schneider A; Scott PA; Starkman S; Warach S; Broderick JP;
Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
[TBL] [Abstract][Full Text] [Related]
53. Higher Left Ventricle Mass Indices Predict Favorable Outcome in Stroke Patients with Thrombolysis.
Wu F; Cao W; Ling Y; Yang L; Cheng X; Dong Q
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1609-13. PubMed ID: 25959501
[TBL] [Abstract][Full Text] [Related]
54. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996
[TBL] [Abstract][Full Text] [Related]
55. Predictors of functional outcome and hemorrhagic complications in acute ischemic stroke patients treated with intravenous thrombolysis - A retrospective analysis
.
Zhao Q; Shan W; Liu L; Fu X; Liu P; Hu Y
Int J Clin Pharmacol Ther; 2017 Dec; 55(12):893-900. PubMed ID: 29092734
[TBL] [Abstract][Full Text] [Related]
56. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
[TBL] [Abstract][Full Text] [Related]
57. Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.
Alonso A; Dempfle CE; Szabo K; Zohsel K; Hennerici MG
Thromb Res; 2011 Jan; 127(1):65-6. PubMed ID: 20537372
[No Abstract] [Full Text] [Related]
58. Clinical implication of hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator.
Ho BL; Chen CF; Lin RT; Liu CK; Chao AC
Neurol Sci; 2016 Nov; 37(11):1799-1805. PubMed ID: 27423451
[TBL] [Abstract][Full Text] [Related]
59. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
60. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
